Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-31
1997-08-12
Conrad, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514478, 514482, 514483, 560 32, 560115, 549221, 564161, 564163, 564212, A61K 31335, A61K 3127, C07C27106, C07C23720
Patent
active
056566603
ABSTRACT:
The present invention describes compounds, methods and compositions effective to treat mast cell mediated inflammatory conditions, such as conjunctivitis, asthma and allergic rhinitis. The compounds of the invention comprise novel mono- and di-aminomethylbenzyl, aminobenzyl, guanidylbenzyl and benzyl tryptase inhibitors. The compositions for treating mast cell mediated inflammatory conditions include oral, inhalant and topical preparations as well as devices comprising such preparations.
REFERENCES:
Miller et al., "Cloning and Characterization of Complementary DNA for Human Tryptase," J. Clin. Invest., 84:1188-1195 (1989).
Miller et al., "Cloning and Characterization of Complementary DNA for Human Tryptase," J. Clin. Invest., 86:864-870 (1990).
Nair et al., "Lithocholic Acid in Human Liver: Identification of .epsilon.-Lithocholyl Lysine in Tissue Protein," Lipids, 12(11):922-929.
Ochi et al., "Synthetic Studies of Vitamin D.sub.3 Analogues from Bile Acids. Part 2. Syntheses of Cholesta-1, 4-dien-and -1, 4, 6-trien-3-ones having a 24-and/or 25-Hydroxylated Side Chain from Lithocholic Acid," J. Chem. Soc. Perkin Trans. I, 1(1):161-164 (1979).
Ruoss et al., "Mast Cell Tryptase Is a Mitogen for Cultured Fibroblasts," J. Clin. Invest., 88:493-499 (1991).
Schwartz et al., "Tryptase Levels as an Indicator of Mast-Cell Activation in Systemic Anaphylaxis and Mastocytosis," N. Engl. J. Med., 316:1622-1626 (1987).
Sekizawa et al., "Mast Cell Tryptase Causes Airway Smooth Muscle Hyperresponsiveness in Dogs," J. Clin. Invest., 83: 175-179 (1989).
Sturzebecher et al., "Inhibition of Human Mast Cell Tryptase by Benzamidine Derivatives," Biol. Chem Hoppe-Seyler, 373:1025-1030 (1992).
Tam et al., "Degradation of Airway Neuropeptides by Human Lung Tryptase," Am. J. Respir. Cell Mol. Biol., 3:27-32 (1990).
Tidwell et al., "Aromatic Amidines: Comparison of Their Ability to Block Respiratory Syncytial Virus Induced Cell Fusion and to Inhibit Plasmin, Urokinase, Thrombin, and Trypsin," J. Med. Chem., 26: 294-298 (1983).
Tidwell et al., "Suppression of Respiratory Syncytial Virus Infection in Cotton Rats by Bis(5-Amidino-2-Benzimidazolyl)Methane," Antimicrobial Agents and Chemotherapy, 26:591-593 (1984).
Vanderslice et al., "Molecular Cloning of Dog Mast Cell Tryptase and a Related Protease: Structural Evidence of a Unique Mode of Serine Protease Activation," Biochemistry, 28:4148-4155 (1989).
Vanderslice et al., "Human mast cell tryptase: Multiple cDNAs and genes reveal a multigene serine protease family," Proc. Natl. Acad. Sci. USA, 87:3811-3815 (1990).
Wanner et al., "Models of Airway Hyperresponsiveness," Am. Rev. Respir. Dis., 141:253-257 (1990).
Wenzel et al., "Activation of Pulmonary Mast Cells by Bronchoalveolar Allergen Challenge," Am. Rev. Resp. Dis., 141:1002-1008 (1988).
Yamada et al., "Synthesis of 24, 24-Difluoro-25-Hydroxyvitamin D.sub.3," Tetrahedron Letters, 21: 1859-1862 (1979).
Bauer Barr E.
Gschwend Heinz W.
Kuo Elaine
Lum Robert T.
Rice Ken
Arris Pharmaceutical Corporation
Conrad Joseph
LandOfFree
Compositions and methods for treating mast-cell mediated conditi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating mast-cell mediated conditi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating mast-cell mediated conditi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-161042